-
1
-
-
84896720556
-
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST)
-
Alaggio R., Turrini R., Boldrin D., Merlo A., Gambini C., Ferrari A., Dall'igna P., Coffin C.M., Martines A., Bonaldi L., De Salvo G.L., Zanovello P., Rosato A. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST) PLoS One 8 2013 e80456
-
(2013)
PLoS One
, vol.8
-
-
Alaggio, R.1
Turrini, R.2
Boldrin, D.3
Merlo, A.4
Gambini, C.5
Ferrari, A.6
Dall'igna, P.7
Coffin, C.M.8
Martines, A.9
Bonaldi, L.10
De Salvo, G.L.11
Zanovello, P.12
Rosato, A.13
-
2
-
-
84898444850
-
Survivin beyond physiology: Orchestration of multistep carcinogenesis and therapeutic potentials
-
Athanasoula K., Gogas H., Polonifi K., Vaiopoulos A.G., Polyzos A., Mantzourani M. Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials Cancer Lett. 347 2014 175 182
-
(2014)
Cancer Lett.
, vol.347
, pp. 175-182
-
-
Athanasoula, K.1
Gogas, H.2
Polonifi, K.3
Vaiopoulos, A.G.4
Polyzos, A.5
Mantzourani, M.6
-
3
-
-
84874821284
-
New strategies in the treatment of ovarian cancer: Current clinical perspectives and future potential
-
Banerjee S., Kaye S.B. New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential Clin. Cancer Res. 19 2013 961 968
-
(2013)
Clin. Cancer Res.
, vol.19
, pp. 961-968
-
-
Banerjee, S.1
Kaye, S.B.2
-
4
-
-
84856741780
-
Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3K/Akt, p38 MAPK and ERK pathways
-
Cao W., Xie Y.H., Li X.Q., Zhang X.K., Chen Y.T., Kang R., Chen X., Miao S., Wang S.W. Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3K/Akt, p38 MAPK and ERK pathways Basic Res. Cardiol. 106 2011 1207 1220
-
(2011)
Basic Res. Cardiol.
, vol.106
, pp. 1207-1220
-
-
Cao, W.1
Xie, Y.H.2
Li, X.Q.3
Zhang, X.K.4
Chen, Y.T.5
Kang, R.6
Chen, X.7
Miao, S.8
Wang, S.W.9
-
5
-
-
84883284979
-
Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen)
-
Chang C.C., Lai J.S., Tsai C.S., Ma S.W., Lin J.Y., Huang L.R., Lu C.H., Liao E.C., Ho T.F. Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen) J. Biosci. Bioeng. 116 2013 516 523
-
(2013)
J. Biosci. Bioeng.
, vol.116
, pp. 516-523
-
-
Chang, C.C.1
Lai, J.S.2
Tsai, C.S.3
Ma, S.W.4
Lin, J.Y.5
Huang, L.R.6
Lu, C.H.7
Liao, E.C.8
Ho, T.F.9
-
6
-
-
84886067499
-
Survivin - Biology and potential as a therapeutic target in oncology
-
Cheung C.H., Huang C.C., Tsai F.Y., Lee J.Y., Cheng S.M., Chang Y.C., Huang Y.C., Chen S.H., Chang J.Y. Survivin - biology and potential as a therapeutic target in oncology Onco Targets Ther. 6 2013 1453 1462
-
(2013)
Onco Targets Ther.
, vol.6
, pp. 1453-1462
-
-
Cheung, C.H.1
Huang, C.C.2
Tsai, F.Y.3
Lee, J.Y.4
Cheng, S.M.5
Chang, Y.C.6
Huang, Y.C.7
Chen, S.H.8
Chang, J.Y.9
-
7
-
-
0038457729
-
Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis
-
Cohen C., Lohmann C.M., Cotsonis G., Lawson D., Santoianni R. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis Mod. Pathol. 16 2003 574 583
-
(2003)
Mod. Pathol.
, vol.16
, pp. 574-583
-
-
Cohen, C.1
Lohmann, C.M.2
Cotsonis, G.3
Lawson, D.4
Santoianni, R.5
-
8
-
-
84875230886
-
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
-
Dimberg L.Y., Anderson C.K., Camidge R., Behbakht K., Thorburn A., Ford H.L. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics Oncogene 32 2013 1341 1350
-
(2013)
Oncogene
, vol.32
, pp. 1341-1350
-
-
Dimberg, L.Y.1
Anderson, C.K.2
Camidge, R.3
Behbakht, K.4
Thorburn, A.5
Ford, H.L.6
-
9
-
-
33846811520
-
P38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis
-
Dolado I., Swat A., Ajenjo N., De Vita G., Cuadrado A., Nebreda A.R. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis Cancer Cell 11 2007 191 205
-
(2007)
Cancer Cell
, vol.11
, pp. 191-205
-
-
Dolado, I.1
Swat, A.2
Ajenjo, N.3
De Vita, G.4
Cuadrado, A.5
Nebreda, A.R.6
-
10
-
-
84893861378
-
Targeting survivin in cancer: Novel drug development approaches
-
Groner B., Weiss A. Targeting survivin in cancer: novel drug development approaches BioDrugs 28 2014 27 39
-
(2014)
BioDrugs
, vol.28
, pp. 27-39
-
-
Groner, B.1
Weiss, A.2
-
11
-
-
36448934493
-
Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53
-
Ho T.F., Ma C.J., Lu C.H., Tsai Y.T., Wei Y.H., Chang J.S., Lai J.K., Cheuh P.J., Yeh C.T., Tang P.C., Tsai Chang J., Ko J.L., Liu F.S., Yen H.E., Chang C.C. Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53 Toxicol. Appl. Pharmacol. 225 2007 318 328
-
(2007)
Toxicol. Appl. Pharmacol.
, vol.225
, pp. 318-328
-
-
Ho, T.F.1
Ma, C.J.2
Lu, C.H.3
Tsai, Y.T.4
Wei, Y.H.5
Chang, J.S.6
Lai, J.K.7
Cheuh, P.J.8
Yeh, C.T.9
Tang, P.C.10
Tsai Chang, J.11
Ko, J.L.12
Liu, F.S.13
Yen, H.E.14
Chang, C.C.15
-
12
-
-
60149100810
-
Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines
-
Ho T.F., Peng Y.T., Chuang S.M., Lin S.C., Feng B.L., Lu C.H., Yu W.J., Chang J.S., Chang C.C. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines Toxicol. Appl. Pharmacol. 235 2009 253 260
-
(2009)
Toxicol. Appl. Pharmacol.
, vol.235
, pp. 253-260
-
-
Ho, T.F.1
Peng, Y.T.2
Chuang, S.M.3
Lin, S.C.4
Feng, B.L.5
Lu, C.H.6
Yu, W.J.7
Chang, J.S.8
Chang, C.C.9
-
13
-
-
34250774915
-
Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells
-
Hsiao P.W., Chang C.C., Liu H.F., Tsai C.M., Chiu T.H., Chao J.I. Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells Toxicol. Appl. Pharmacol. 222 2007 97 104
-
(2007)
Toxicol. Appl. Pharmacol.
, vol.222
, pp. 97-104
-
-
Hsiao, P.W.1
Chang, C.C.2
Liu, H.F.3
Tsai, C.M.4
Chiu, T.H.5
Chao, J.I.6
-
14
-
-
79953655787
-
Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
-
Kelly R.J., Lopez-Chavez A., Citrin D., Janik J.E., Morris J.C. Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin Mol. Cancer 10 2011 35
-
(2011)
Mol. Cancer
, vol.10
, pp. 35
-
-
Kelly, R.J.1
Lopez-Chavez, A.2
Citrin, D.3
Janik, J.E.4
Morris, J.C.5
-
16
-
-
84878648322
-
Prognostic and clinicopathological significance of survivin in colorectal cancer: A meta-analysis
-
Krieg A., Werner T.A., Verde P.E., Stoecklein N.H., Knoefel W.T. Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis PLoS One 8 2013 e65338
-
(2013)
PLoS One
, vol.8
-
-
Krieg, A.1
Werner, T.A.2
Verde, P.E.3
Stoecklein, N.H.4
Knoefel, W.T.5
-
18
-
-
77956495728
-
Ovarian cancer development and metastasis
-
Lengyel E. Ovarian cancer development and metastasis Am. J. Pathol. 177 2010 1053 1064
-
(2010)
Am. J. Pathol.
, vol.177
, pp. 1053-1064
-
-
Lengyel, E.1
-
19
-
-
84922496579
-
Tanshinone IIA inhibits HIF-1alpha and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway
-
Li G., Shan C., Liu L., Zhou T., Zhou J., Hu X., Chen Y., Cui H., Gao N. Tanshinone IIA inhibits HIF-1alpha and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway PLoS One 10 2015 e0117440
-
(2015)
PLoS One
, vol.10
-
-
Li, G.1
Shan, C.2
Liu, L.3
Zhou, T.4
Zhou, J.5
Hu, X.6
Chen, Y.7
Cui, H.8
Gao, N.9
-
20
-
-
78149464260
-
Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells
-
Liu H.F., Hu H.C., Chao J.I. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells Chem. Biol. Interact. 188 2010 535 545
-
(2010)
Chem. Biol. Interact.
, vol.188
, pp. 535-545
-
-
Liu, H.F.1
Hu, H.C.2
Chao, J.I.3
-
21
-
-
84908032208
-
Aplysin sensitizes cancer cells to TRAIL by suppressing p38 MAPK/survivin pathway
-
Liu J., Ma L., Wu N., Liu G., Zheng L., Lin X. Aplysin sensitizes cancer cells to TRAIL by suppressing p38 MAPK/survivin pathway Mar. Drugs 12 2014 5072 5088
-
(2014)
Mar. Drugs
, vol.12
, pp. 5072-5088
-
-
Liu, J.1
Ma, L.2
Wu, N.3
Liu, G.4
Zheng, L.5
Lin, X.6
-
22
-
-
84898872892
-
Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: A meta-analysis
-
Lv S., Turlova E., Zhao S., Kang H., Han M., Sun H.S. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis Tumour Biol. 35 2014 1565 1574
-
(2014)
Tumour Biol.
, vol.35
, pp. 1565-1574
-
-
Lv, S.1
Turlova, E.2
Zhao, S.3
Kang, H.4
Han, M.5
Sun, H.S.6
-
23
-
-
84919460678
-
Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer
-
Munagala R., Aqil F., Jeyabalan J., Gupta R.C. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer Cancer Lett. 356 2015 536 546
-
(2015)
Cancer Lett.
, vol.356
, pp. 536-546
-
-
Munagala, R.1
Aqil, F.2
Jeyabalan, J.3
Gupta, R.C.4
-
24
-
-
84861575622
-
Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis
-
Ryu B.J., Hwang M.K., Park M., Lee K., Kim S.H. Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis Bioorg. Med. Chem. Lett. 22 2012 3862 3865
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 3862-3865
-
-
Ryu, B.J.1
Hwang, M.K.2
Park, M.3
Lee, K.4
Kim, S.H.5
-
25
-
-
14844288360
-
Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: Paving the road to patient-tailored therapy
-
Van Geelen C.M., de Vries E.G., de Jong S. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy Drug Resist. Update 7 2004 345 358
-
(2004)
Drug Resist. Update
, vol.7
, pp. 345-358
-
-
Van Geelen, C.M.1
De Vries, E.G.2
De Jong, S.3
-
26
-
-
8344271026
-
Production of recombinant protein therapeutics in cultivated mammalian cells
-
Wurm F.M. Production of recombinant protein therapeutics in cultivated mammalian cells Nat. Biotechnol. 22 2004 1393 1398
-
(2004)
Nat. Biotechnol.
, vol.22
, pp. 1393-1398
-
-
Wurm, F.M.1
-
27
-
-
0035464197
-
Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas
-
Yoshida H., Ishiko O., Sumi T., Matsumoto Y., Ogita S. Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas Int. J. Oncol. 19 2001 537 542
-
(2001)
Int. J. Oncol.
, vol.19
, pp. 537-542
-
-
Yoshida, H.1
Ishiko, O.2
Sumi, T.3
Matsumoto, Y.4
Ogita, S.5
-
28
-
-
0034532701
-
The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner
-
Zhao J., Tenev T., Martins L.M., Downward J., Lemoine N.R. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner J. Cell Sci. 113 2000 4363 4371
-
(2000)
J. Cell Sci.
, vol.113
, pp. 4363-4371
-
-
Zhao, J.1
Tenev, T.2
Martins, L.M.3
Downward, J.4
Lemoine, N.R.5
|